Drreddys Laboratories | RDY - Passivo Circulante





Passivo Circulante Alterar Data
ANI Pharmaceuticals USD 239.51M 38.6M 2026-03
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bayer EUR 33.46B 875M 2026-03
Canopy Growth CAD 98.29M 17.19M 2025-12
Cipla INR 70.14B 7.16B 2026-03
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Drreddys Laboratories INR 1.76B 62.5M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lonza CHF 3.57B 421M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Pacira USD 108.79M 11.8M 2026-03
Phibro Animal Health USD 281.87M 500K 2026-03
Prestige Brands USD 120.92M 18.63M 2026-03
Richter Gedeon HUF 179.31B 8.13B 2026-03
Sun Pharmaceuticals INR 226.22B 7.93B 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03